Results of pharmaceutical care program disappoint researchers

2002 ◽  
Vol 59 (22) ◽  
pp. 2146-2146 ◽  
Author(s):  
Donna Young
Keyword(s):  
Pharmaceutical Care ◽  
Care Program

Pharmaceutical care program in a service to people with disabilities

2012 ◽  
Vol 19 (2) ◽  
pp. 203.3-204
Author(s):  
C. Martínez Roca ◽  
A. Fernández Pérez ◽  
I. López Rodríguez ◽  
V.M. López García ◽  
P. Castellano Copa ◽  
...  
Keyword(s):  
Pharmaceutical Care ◽  
People With Disabilities ◽  
Care Program

scholarly journals Effect of a 36-month Pharmaceutical Care Program on the Coronary Heart Disease Risk in Elderly Diabetic and Hypertensive Patients

2011 ◽  
Vol 14 (2) ◽  
pp. 249 ◽  
Author(s):  
Paulo Roque Obreli Neto ◽  
Srecko Marusic ◽  
Divaldo Pereira De Lyra Júnior ◽  
Diogo Pilger ◽  
Joice Mara Cruciol-Souza ◽  
...  
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Pharmaceutical Care ◽  
Coronary Heart Disease Risk ◽  
Disease Risk ◽  
Intervention Group ◽  
Care Program ◽  
Control Group ◽  
Hypertensive Patients ◽  
Heart Disease Risk

Purpose. To examine the effect of a pharmaceutical care program on the coronary heart disease risk in elderly diabetic and hypertensive patients. Methods. A total of 200 elderly (> 60 years) diabetic and/or hypertensive patients were recruited into a randomized, controlled, prospective clinical trial with a 36-month follow-up, developed in a public primary health care unit in a municipality in the Brazilian State of Sao Paulo. A range of clinical measurements were evaluated at the baseline and up to 36 months afterwards. The intervention group patients received pharmaceutical care from a clinical pharmacist, whereas the control group patients received their usual care from the medical and nursing staff. The Framingham scoring method was used to estimate changes in the 10-year coronary heart disease risk scores of all the patients. Results. A total of 194 patients completed the study. Significant reductions (p < 0.05) in the mean values (baseline vs. 36 months) for the systolic blood pressure [156.7mmHg vs 133.7mmHg; p

Pharmaceutical care program for patients with reactive airways disease

2001 ◽  
Vol 58 (9) ◽  
pp. 791-796 ◽  
Author(s):  
Morris Weinberger ◽  
Michael D. Murray ◽  
David G. Marrero ◽  
Nancy Brewer ◽  
Michael Lykens ◽  
...  
Keyword(s):  
Pharmaceutical Care ◽  
Care Program ◽  
Reactive Airways

Pharmaceutical care program for elderly patients with uncontrolled hypertension

2012 ◽  
Vol 52 (4) ◽  
pp. 515-518 ◽  
Author(s):  
Patricia M. Aguiar ◽  
Blicie J. Balisa-Rocha ◽  
Giselle C. Brito ◽  
Divaldo P. Lyra
Keyword(s):  
Elderly Patients ◽  
Pharmaceutical Care ◽  
Care Program ◽  
Uncontrolled Hypertension
Sign in / Sign up

Export Citation Format

Share Document